Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6.21	14.69	9.6	34.89	32.67	3.9
Short-Term Investments	33.7	24.79	31.82	0	0	5.99
Cash & Cash Equivalents	39.92	39.49	41.42	34.89	32.67	9.89
Cash Growth	-11.63%	-4.67%	18.74%	6.79%	230.45%	31.07%
Receivables	0.37	10.37	0.55	0.39	0	0.09
Other Current Assets	1.13	1	0.92	1.16	1.01	0.57
Total Current Assets	41.41	50.86	42.89	36.44	33.68	10.54
Property, Plant & Equipment	7.74	7.61	6.94	4.62	0.85	0.44
Goodwill and Intangibles	0	0	0	0	0	0.01
Other Long-Term Assets	0.29	0.27	0.27	0.28	0.09	0.12
Total Long-Term Assets	8.03	7.88	7.21	4.89	0.94	0.57
Total Assets	49.44	58.73	50.09	41.33	34.62	11.11
Accounts Payable	6.25	6.25	4.92	3.72	2.72	0.9
Deferred Revenue	19.36	24.27	27.45	0	0	0
Current Debt	0.77	0.75	0.68	0.42	0.25	0
Other Current Liabilities	0	0	-9.47	0	0	0
Total Current Liabilities	26.38	31.27	23.59	4.13	2.97	0.9
Long-Term Debt	1.25	1.49	1.88	2.45	0.07	0
Other Long-Term Liabilities	3.38	3.38	12.84	3.38	3.38	3.38
Total Long-Term Liabilities	4.63	4.86	14.72	5.83	3.45	3.38
Total Liabilities	31.01	36.13	38.31	9.96	6.42	4.27
Total Debt	2.02	2.24	2.56	2.87	0.32	0
Debt Growth	-15.56%	-12.66%	-10.81%	802.17%	-	-
Retained Earnings	-169.16	-159.37	-137.08	-108.06	-88.04	-74.38
Comprehensive Income	0.31	0.24	0.11	0	0	-0
Shareholders' Equity	18.43	22.6	11.79	31.37	28.2	6.84
Net Cash / Debt	37.9	37.25	38.86	32.01	32.35	9.89
Net Cash / Debt Growth	-11.41%	-4.14%	21.38%	-1.03%	227.23%	31.07%
Net Cash Per Share	1.21	1.39	1.58	1.39	2.08	2.66
Working Capital	15.03	19.59	19.3	32.3	30.71	9.65
Book Value Per Share	0.59	0.84	0.48	1.36	1.81	1.84

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).